Compound Detail
CHEMBL1234354
PF-04691502 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1234354 |
| Name | PF-04691502 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | XDLYKKIQACFMJG-WKILWMFISA-N |
16
Targets
45
Activities
3
Assay Types
7
PK Parameters
20
Publications
2
Known Names
3
Indications
2
Mechanisms
Molecular Properties
425.5
MW (Da)
2.25
ALogP
9
HBA
2
HBD
125.4
PSA (Ų)
0.62
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase mTOR inhibitor | INHIBITOR | Serine/threonine-protein kinase mTOR | ✓ | ✓ |
| PI3-kinase class I inhibitor | INHIBITOR | PI3-kinase class I | ✓ | ✓ |
Indications
Breast Neoplasms Breast Neoplasms Neoplasms
Activity Summary
IC50 26 meas. best 8.8
Ki 18 meas. best 9.24
Kd 1 meas. best 5.81
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 5.2 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 25.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 10.72 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| F | 56.0 | % | Rattus norvegicus |
| Fu | 0.202 | - | Rattus norvegicus |
| T1/2 | 3.1 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5303300 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5303300 | U2OS | 304 |
| - | 10.6019/CHEMBL5303300 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 9 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 8 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 8 |
| - | 10.1039/C0MD00072H | Rattus norvegicus | 6 |
| - | 10.6019/CHEMBL5303304 | U2OS | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| - | 10.6019/CHEMBL4495565 | ADMET | 4 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 4 |
| - | 10.1039/C0MD00072H | Unchecked | 2 |
| 25139570 | 10.1016/j.bmcl.2014.07.073 | ADMET | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL3301361 | No relevant target | 2 |
| 36503229 | 10.1021/acs.jmedchem.2c01070 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 2 |
| 36503229 | 10.1021/acs.jmedchem.2c01070 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2 |
| 36503229 | 10.1021/acs.jmedchem.2c01070 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2 |
| 23506825 | 10.1016/j.bmcl.2013.02.020 | Plasma | 2 |
| 36503229 | 10.1021/acs.jmedchem.2c01070 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 2 |
Data from ChEMBL 36 via Core Engine